FoxScore

Analysis for Roche

ROG.CH · As of: 02/17/2026
Basic information
Type: Stock
Region: Europe
Sector: Health Care
TER:
History
Available history:15.0 years
Last tradingday:02/17/2026
Description & usage
Roche is a Swiss healthcare group with major businesses in pharmaceuticals and diagnostics. In pharma, innovation, label expansions and pipeline progress are central factors, while diagnostics depends on testing volumes, product cycles and lab demand. As with many large pharma names, patent expiries, competition and regulatory decisions can materially influence the stock.
Overall score 54Performance 36Stability 67Trend 820255075100PerformanceStabilityTrend
Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

Roche (ROG.CH) currently has a total score of 54 points, placing it in the neutral range. The score is made up of Performance (36), Stability (67) and Trend (82). The profile is clearly uneven: Trend stands out while Performance lags.

Performance scores 36 points (weak). Key strength: 1Y return at 25.4 %. Main drag: 10Y return at 45.1 %. This points to a sharper upswing more recently.

Stability scores 67 points (strong). Key strength: Sortino ratio (90d) at 4.67. Main drag: CAGR/drawdown ratio at 0.08. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 82 points (very strong). Key strength: Price is about 28.1 % above SMA200. Even the weakest metric remains solid in absolute terms: 12M momentum at 18.9 %.

Overall, the picture is mixed: Trend does the heavy lifting while Performance holds the score back. On a metric level, Sortino ratio (90d) stands out, while 10Y return lags.

(Historical evaluation, not investment advice.)

Chart anzeigen
Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

FAQ

What investor type does Roche fit best in FoxScore?
Roche fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
How meaningful is the available history for Roche?
Roche currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?
FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.